Kenro Nishida
Kumamoto, 8620965, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD).
Journal: Biomedicines
Published: April 10, 2025
Benefits and Accuracy of Real-Time CGM in Children and Adolescents With Type 1 Diabetes Attending Summer Camp: Second Year.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 16, 2024
The benefits and accuracy of real-time continuous glucose monitoring in children and adolescents with type 1 diabetes attending a summer camp.
Journal: Journal of diabetes investigation
Published: July 11, 2024
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective study.
Journal: Diabetes, obesity & metabolism
Published: November 24, 2023
Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study.
Journal: Endocrine journal
Published: July 17, 2019
Novel Imaging of Hypoglycemia-induced Myocardial Abnormality by Cardiac Magnetic Resonance T1-mapping.
Journal: Internal medicine (Tokyo, Japan)
Published: October 13, 2017
Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy.
Journal: Endocrine journal
Published: November 14, 2014
Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy.
Journal: Endocrine journal
Published: August 06, 2013
Comparison of the efficacy of sitagliptin and glimepiride dose-up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination.
Journal: Journal of diabetes investigation
Published: April 19, 2013
Effects of olmesartan, an angiotensin II receptor blocker, on peripheral insulin sensitivity in Japanese subjects with type 2 diabetes and hypertension.
Journal: Internal medicine (Tokyo, Japan)
Published: August 16, 2012
Ezetimibe improves glucose metabolism by ameliorating hepatic function in Japanese patients with type 2 diabetes.
Journal: Journal of diabetes investigation
Published: March 28, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026